廣州基金國際控股(01367.HK)附屬擬投資生豬養殖及食品加工公司興疆牧歌
格隆匯 1 月 13日丨廣州基金國際控股(01367.HK)發佈公吿,2021年1月13日,湖南匯垠天星(公司持有51%權益的附屬公司)通過合夥企業投資興疆牧歌,合夥企業乃專為投資興疆牧歌而成立的實體。湖南匯垠天星(作為合夥企業的有限合夥人)及中青恆輝(獨立第三方,作為合夥企業的普通合夥人)已分別向合夥企業出資人民幣2000萬元及人民幣10萬元。
興疆牧歌為於2017年6月根據中國法律成立的有限公司。其主要在中國從事生豬養殖及食品加工。目前在新疆、廣西、甘肅及青海擁有六間養豬場及在新疆擁有兩間屠宰場。興疆牧歌管理層在生豬養殖及╱或相關業務方面擁有逾十年的經驗。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.